Rezafungin (CD101), a next-generation echinocandin: A systematic literature review and assessment of possible place in therapy

Sofjan, AK; Mitchell, A; Shah, DN; Nguyen, T; Sim, M; Trojcak, A; Beyda, ND; Garey, KW

Garey, KW (reprint author), Univ Houston, Coll Pharm, Dept Pharm Practice & Translat Res, 4849 Calhoun Rd, Houston, TX 77204 USA.

JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2018; 14 (): 58

Abstract

Objectives: Rezafungin (CD101) is a novel echinocandin currently under development. The purpose of this study was to perform a systematic literature r......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索